CompletedNot Applicable

Psychiatry of Transition in a World in Transition

Belgium252 participantsStarted 2020-06-10

Plain-language summary

This clinical study evaluates risk and protective factor to develop psychopathology in transitional age youth. 300 patients will be recruited at the age of 17 years old and assessed at baseline and 2 years later.

Who can participate

Age range

17 Years – 17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * French-speaking and French-understanding * Subjects who accepted to participated to the study (signature of informed consent/assent document from subjects and parents or legal holder of parental authority) * Specific criteria for patients: inpatients and out-patients * Specific criteria for control group: youth from general population or placed in residential centres Exclusion Criteria: * Impossibility to answer to the assessment tools * Medium intellectual disability (homogenous IQ \< 75) * Presence of a grave somatic disease (cancer, cardiac failure, renal failure, central nervous system disorder), that is progressive or that affects the vital prognosis in the short term * Active participation to another study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from Baseline self-rated mental health status (need for care) at 2 years

Timeframe: Change from Baseline HoNOSCA before transition at 17 y.o. to after transition at 19 y.o.

Change from Baseline self-rated measure of quality of life at 2 years

Timeframe: Change from Baseline WHO-QoL before transition at 17 y.o. to after transition at 19 y.o

Trial details

NCT IDNCT04333797

SponsorQueen Fabiola Children's University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Transitional Care trials